Skip to content
The Cancer History Project
HOME
ABOUT
THE CANCER HISTORY PROJECT
THE CANCER LETTER
EDITORIAL BOARD
SPONSORS
CONTRIBUTORS
TCL ARCHIVES
LATEST ARTICLES
Search for:
Search
ARCHIVES
FDA Commissioner Says Swifter Drug Approvals, Enforcement Emphasis Characterize ‘Today’s FDA’
This article is from
The Cancer Letter
archive.
Vol. 18 No. 05 | January 31, 1992
Download PDF
Visit The Full Archive
Related Articles
TCL Archive
Frozen Section Analysis Helps Avoid Second Surgery
September 30, 2005
TCL Archive
DCCPT Board, NCAB Approve Core Grant Guideline Changes, Consortium Centers
May 17, 1985
TCL Archive
House Committee Gives NCI Only $6.5 Million Over President’s request
July 28, 1989
TCL Archive
NCAB Criticizes Coverage’ Of NCI Screening Statement
March 4, 1994
TCL Archive
Alan Rabson Outlasts Them All, Even His Bosses, As DCBD Chief
January 15, 1982
TCL Archive
Bristol-Myers Cancer Scientist Award Nominations To Close March 1
February 24, 1978